ALK and neoplasm: Transcriptome sequencing enables the identification of oncogenic gene fusions (e.g., ALK, ROS1, NTRK, BCR-ABL1, ETV6-NTRK3), alternative splicing events, allele-specific expression patterns, and quantitative transcript levels, thereby capturing both functional and regulatory dimensions of tumor biology.